Search Results - "Anibarro, L"

Safety and efficacy of the C-Tb skin test to diagnose Mycobacterium tuberculosis infection, compared with an interferon γ release assay and the tuberculin skin test: a phase 3, double-blind, randomised, controlled trial by Ruhwald, Morten, Dr, Aggerbeck, Henrik, DMSc, Gallardo, Rafael Vázquez, MD, Hoff, Søren T, MD, Villate, José I, Prof, Borregaard, Bettine, RN, Martinez, José A, Kromann, Ingrid, MSc, Penas, Antón, MD, Anibarro, Luis L, MD, de Souza-Galvão, Maria Luiza, MD, Sánchez, Francisca, MD, Rodrigo-Pendás, Jose Ángel, MD, Noguera-Julian, Antoni, MD, Martínez-Lacasa, Xavier, MD, Tuñez, Maria Victoria, MD, Fernández, Virginia Leiro, MD, Millet, Joan P, MD, Moreno, Antonio, MD, Cobos, Nazaret, Miró, José M, MD, Roldan, Llanos, RN, Orcau, Angels, MD, Andersen, Peter, DMSc [Vet], Caylá, Joan A, MD

“…Summary Background Targeted screening and treatment of Mycobacterium tuberculosis infection substantially reduces the risk of developing active tuberculosis…”
Get full text

Recent epidemiological trends in extrapulmonary TB in Galicia, Spain by Ferreiro, L., Ruano-Raviña, A., Otero-Mallo, R., Pou-Álvarez, C., Riveiro-Blanco, V., Casal, A., Suárez-Antelo, J., Toubes, M. E., Cruz-Ferro, E., Rodríguez-Núñez, N., Ursúa-Díaz, M. I., Lama, A., Piñeiro-Lamas, M., Rábade, C., Zamarrón, C., González-Barcala, F. J., Valiño-López, P., Anibarro, L., Taboada-Rodríguez, J. A., Valdés, L., Galician Programme for the Prevention and Control of Tuberculosis

“…OBJECTIVE: To describe the epidemiological trends and characteristics of extrapulmonary tuberculosis (EPTB) in Galicia, Spain, from 2000 to 2019.METHODS: This…”
Get full text

Interferon-γ release assays in tuberculosis contacts: is there a window period? by ANIBARRO, L, TRIGO, M, VILLAVERDE, C, PENA, A, CORTIZO, S, SANDE, D, PAZOS, R. A, GONZALEZ-FERNANDEZ, A

Get full text

Detection of interleukin-2 is not useful for distinguishing between latent and active tuberculosis in clinical practice: a prospective cohort study by Santin, M., Morandeira-Rego, F., Alcaide, F., Rabuñal, R., Anibarro, L., Agüero-Balbín, R., Casas-Garcia, X., Pérez-Escolano, E., Navarro, M.D., Sánchez, F., Coira-Nieto, A., Trigo-Daporta, M., Martinez-Meñaca, A., Gonzalez-Cuevas, A., López-Prieto, M.D., Domínguez-Castellano, A., Jové, N., Struzka, Edu A., Climent, Joan, Penas-Truque, Antón, Pallarés-Sanmartín, Abel, Ríos, Mónica, Pargada-Ferrer, Diego J., Agüero-Balbin, Jesús, Rodríguez-Gutiérrez, Juan F.

“…Previous reports have identified interleukin-2 (IL-2), quantified in the supernatants of QuantiFERON®-TB Gold In-tube (QFT) after 72 h of incubation, as a…”
Get full text

Epidemiology of tuberculosis in Galicia, Spain, 16 years after the launch of the Galician tuberculosis programme by Cruz-Ferro, E., Ursúa-Díaz, M. I., Taboada-Rodríguez, J. A., Hervada-Vidal, X., Anibarro, L., Túñez, V., The Galician Tuberculosis Prevention and Control Programme Working Group

“…SETTING: Galicia, Spain.OBJECTIVE: To describe changes in tuberculosis (TB) epidemiology and characteristics in Galicia, Spain, during the period…”
Get full text

Treatment completion in latent tuberculosis infection at specialist tuberculosis units in Spain by ANIBARRO, L, CASAS, S, PAZ-ESQUETE, J, GONZALEZ, L, PENA, A, GUERRA, M. R, SANDE, D, CALVINO, L, SANTIN, M

“…SETTING: Treatment of latent tuberculosis infection (LTBI) is essential for tuberculosis (TB) control in low-prevalence countries. However, the long treatment…”
Get full text

Toxicity and adherence to treatment for latent tuberculosis infection in patients with hematologic malignancies by Sánchez-García, E. M., Gamallo, R., Blanco-Moure, A., Viejo, M. A., Amador, L., Anibarro, L.

“…Purpose Oncohematological patients undergoing chemotherapy who have latent tuberculosis infection (LTBI) are at a high risk of developing active tuberculosis…”
Get full text

Multidrug-resistant tuberculosis in a low-incidence region shows a high rate of transmission by VAZQUEZ-GALLARDO, R, ANIBARRO, L, FERNANDEZ-VILLAR, A, DIAZ-CABANELA, D, CRUZ-FERRO, E, PEREZ DEL MOLINO, M. L, TUNEZ, V, SAMPER, S, IGLESIAS, M. J

“…OBJECTIVE: To describe the characteristics of patients with multidrug-resistant tuberculosis (MDR-TB), a descriptive prospective study was carried out applying…”
Get full text

Study of Mycobacterium tuberculosis drug resistance in the region of Galicia, Spain by del Molino Bernal, MLP, Tunez, V, Cruz-Ferro, E, Fernandez-Villar, A, Vazquez-Gallardo, R, Diaz-Cabanela, D, Anibarro, L

“…FRAMEWORK: Galicia, a region in north-east Spain with its own government and health system and a population of 2695880.OBJECTIVE: To study the epidemiology of…”
Get full text

Relationship between thyroid dysfunction and body weight: a not so evident paradigm by Ríos-Prego, Mónica, Anibarro, Luis, Sánchez-Sobrino, Paula

“…Hypothyroidism has traditionally been associated with obesity, whereas hyperthyroidism has been linked to being underweight. However, very few studies have…”
Get full text

Factors Associated with Fatality during the Intensive Phase of Anti-Tuberculosis Treatment by Rodrigo, T, Casals, M, Caminero, J A, García-García, J M, Jiménez-Fuentes, M A, Medina, J F, Millet, J P, Ruiz-Manzano, J, Caylá, J

“…To determine the case-fatality rate (CFR) at the end of the intensive phase of tuberculosis (TB) treatment, and factors associated with fatality. TB patients…”
Get full text

In Reply by Cruz-Ferro, E., Ursúa-Díaz, M. I., Taboada-Rodríguez, J. A., Hervada-Vidal, X., Anibarro, L., Túñez, V., Galician Tuberculosis Prevention And Control

Get full text

In Reply by Cruz-Ferro, E., Ursúa-Díaz, M. I., Taboada-Rodríguez, J. A., Hervada-Vidal, X., Anibarro, L., Túñez, V., Galician Tuberculosis Prevention And Control Programme Working Group

Get full text

A predictive scoring instrument for tuberculosis lost to follow-up outcome by Rodrigo, Teresa, Caylà, Joan A, Casals, Martí, García-García, José M, Caminero, José A, Ruiz-Manzano, Juan, Blanquer, Rafael, Vidal, Rafael, Altet, Neus, Calpe, José L, Penas, Antón

“…Adherence to tuberculosis (TB) treatment is troublesome, due to long therapy duration, quick therapeutic response which allows the patient to disregard about…”
Get full text

In reply by Cruz-Ferro, E, Ursúa-Díaz, M I, Taboada-Rodríguez, J A, Hervada-Vidal, X, Anibarro, L, Túñez, V

Get full text

In reply by Cruz-Ferro, E, Ursúa-Díaz, M I, Taboada-Rodríguez, J A, Hervada-Vidal, X, Anibarro, L, Túñez, V

Get full text

Effectiveness of Dimethyl Fumarate in Real-World Clinical Practice and Strategy to Minimize Adverse Effects and Use of Healthcare Resources by Rodríguez-Regal, Ana, Ramos-Rúa, Laura, Anibarro-García, Luis, Lopez Real, Ana María, Amigo-Jorrín, María Del Campo

“…Dimethyl fumarate (DMF) has shown efficacy in reducing relapse rates in patients with multiple sclerosis (MS). However, associated adverse effects (AE) such as…”
Get full text

Diagnosis of functional kidney failure of cirrhosis with Doppler sonography: prognostic value of resistive index by Maroto, A, Ginès, A, Saló, J, Clària, J, Ginès, P, Anibarro, L, Jiménez, W, Arroyo, V, Rodés, J

“…Time-velocity wave-form analysis of Doppler signals from small intrarenal arteries allows estimation of intrarenal arteriolar vascular resistance. Among the…”
Get more information

Study of Mycobacterium tuberculosis drug resistance in the reqion of Galicia, Spain by PEREZ DEL MOLINO BERNAL, M. L, TUNEZ, V, CRUZ-FERRO, E, FERNANDEZ-VILLAR, A, VAZQUEZ-GALLARDO, R, DIAZ-CABANELA, D, ANIBARRO, L

Get full text

Actinomicosis primaria de la pared abdominal: Descripción de dos casos y revisión de la literatura by García García, J. C., Núñez Fernández, M. J., Cerqueiro González, J. M., García Martín, C., Rodríguez García, J. C., Anibarro García, L., Lis Muñoz, J. M. de, Piñeiro Gómez-Durán, L.

Get full text